BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

294 related articles for article (PubMed ID: 11785354)

  • 21. [Prevention of neonatal alloimmune thrombocytopenia fetal maternal rhesus].
    Poissonnier MH
    J Gynecol Obstet Biol Reprod (Paris); 2007 Sep; 36 Suppl 1():S12-5. PubMed ID: 18228707
    [No Abstract]   [Full Text] [Related]  

  • 22. Anti-D immunoglobulin in RhD prophylaxis.
    Robson SC; Lee D; Urbaniak S
    Br J Obstet Gynaecol; 1998 Feb; 105(2):129-34. PubMed ID: 9501773
    [No Abstract]   [Full Text] [Related]  

  • 23. Compliance with routine antenatal rhesus D prophylaxis and the impact on sensitisations: observations over 14 years.
    MacKenzie IZ; Findlay J; Thompson K; Roseman F
    BJOG; 2006 Jul; 113(7):839-43. PubMed ID: 16827770
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Hemolytic disease of the newborn has not vanished from Finland--routine protection of RhD negative mothers during pregnancy is justifiable].
    Sainio S; Kuosmanen M
    Duodecim; 2012; 128(2):151-7. PubMed ID: 22372070
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Anti-D administration in early pregnancy--time for a new protocol.
    Carmody F
    Aust N Z J Obstet Gynaecol; 1996 May; 36(2):227-8. PubMed ID: 8798328
    [No Abstract]   [Full Text] [Related]  

  • 26. Efficacy and safety of monoclonal anti-D immunoglobulin in comparison with polyclonal anti-D immunoglobulin in prevention of rho isoimmunization.
    Chauhan AR; Bhattacharyya MS; Turakhia N; Daftary GV
    J Assoc Physicians India; 2002 Oct; 50():1341-2. PubMed ID: 12568238
    [No Abstract]   [Full Text] [Related]  

  • 27. The use of anti-D immunoglobulins for rhesus prophylaxis: audit on knowledge and practices among obstetricians.
    Wee WW; Kanagalingam D
    Singapore Med J; 2009 Nov; 50(11):1054-7. PubMed ID: 19960158
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Anti-D administration after childbirth for preventing Rhesus isoimmunisation.
    Anderson T
    Pract Midwife; 1999 May; 2(5):10-1. PubMed ID: 12024602
    [No Abstract]   [Full Text] [Related]  

  • 29. [Rhesus prophylaxis--history and current status].
    Behrens O; Lellé RJ
    Zentralbl Gynakol; 1997; 119(5):204-10. PubMed ID: 9281253
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Kleihauer testing. Many cases of sensitisation may be avoidable.
    Murphy WG; Ghosh S; Hughes RH; Craig JI; Greer IA
    BMJ; 1994 Sep; 309(6957):806. PubMed ID: 7848430
    [No Abstract]   [Full Text] [Related]  

  • 31. The kinetics of routine antenatal prophylactic intramuscular injections of polyclonal anti-D immunoglobulin.
    MacKenzie IZ; Roseman F; Findlay J; Thompson K; Jackson E; Scott J; Reed M
    BJOG; 2006 Jan; 113(1):97-101. PubMed ID: 16398777
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Economics of antenatal prophylaxis.
    Cairns JA
    Br J Obstet Gynaecol; 1998 Nov; 105 Suppl 18():19-22. PubMed ID: 9863974
    [No Abstract]   [Full Text] [Related]  

  • 33. Preventing RhD haemolytic disease of the newborn. Revised guidelines advocate two doses of anti-D immunoglobulin for antenatal prophylaxis.
    Lee D
    BMJ; 1998 May; 316(7144):1611. PubMed ID: 9596614
    [No Abstract]   [Full Text] [Related]  

  • 34. Anti-D. Part 2: Risks and benefits.
    Wickham S
    Pract Midwife; 1999 Jun; 2(6):38-9. PubMed ID: 10481677
    [No Abstract]   [Full Text] [Related]  

  • 35. An audit of the investigation and use of anti-D immunoglobulin prophylaxis in Tayside.
    Rennie I; Smith A; Smith R; Rawlinson PS; Clark P
    Health Bull (Edinb); 2001 May; 59(3):150-4. PubMed ID: 12664753
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antenatal Rh iso-immunization prophylaxis: implications for blood bank assessment.
    Larison J; Fadel H; Squires J; Barnwell C
    J Med Assoc Ga; 1985 Aug; 74(8):560-1. PubMed ID: 2995529
    [No Abstract]   [Full Text] [Related]  

  • 37. Kleihauer testing. Need not be abandoned.
    Love EM; Shwe KH
    BMJ; 1994 Sep; 309(6957):805. PubMed ID: 7950581
    [No Abstract]   [Full Text] [Related]  

  • 38. Kleihauer testing. Quality assurance scheme exists.
    Urbaniak SJ; Main R; Fraser N
    BMJ; 1994 Sep; 309(6957):805. PubMed ID: 7950582
    [No Abstract]   [Full Text] [Related]  

  • 39. Prevention of post-transfusion RhD immunization using red cell exchange and intravenous anti-D immunoglobulin.
    Laspina S; O'riordan JM; Lawlor E; Murphy WG
    Vox Sang; 2005 Jul; 89(1):49-51. PubMed ID: 15938740
    [No Abstract]   [Full Text] [Related]  

  • 40. [Anti-erythrocyte alloimmunization in an obstetrical milieu. Study of 2093 cases].
    Gargouri J; Khemiri H; Feki H; Rekik H; Rekik S
    Tunis Med; 2002 May; 80(5):255-9. PubMed ID: 12534028
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.